Abbott India Ltd - 500488 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0651 Name of the Signatory :- Krupa AnandparaDesignation :- Company Secretary and Compliance Officer
Rebound in domestic market lifts Abbott India's prospects
During Q4, the firm had reported 14% year-on-year growth, outperforming the pharma market growth Abbott India Ltd - 500488 - Reg. 34 (1) Annual Report
This is to inform you that the Seventy-seventh Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, July 27, 2021 at 9:30 a.m. (IST) through Video-Conferencing (''VC'')/Other Audio-Visual Means ('OAVM') in accordance with the relevant circulars issued by the Ministry of Corporate Affairs ('MCA') and the Securities and Exchange Board of India ('SEBI'). We hereby enclose a copy of the Annual Report of the Company for the financial year ended March 31, 2021, for your records. You are requested to take the same on record. Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed the Public Notice, inter-alia, informing about the Seventy-seventh Annual General Meeting of the Company along with the details of the remote e-voting facility and e-voting at the Annual General Meeting, Book Closure dates and Dividend, published in the Business Standard (All Editions) and Loksatta on Saturday, July 3, 2021. You are requested to take the same on record. ABBOTT INDIA LTD. - 500488 - Closure of Trading Window
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Shares of the Company by the Designated Persons and their immediate relatives shall be closed from today i.e. Wednesday, June 30, 2021 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2021. You are requested to take the same on record. Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to our earlier letter dated June 24, 2021 regarding the Institutional Shareholders/Analysts Meet, please note that the complete recording of the Meeting is available on the website of the Company at www.abbott.co.in. Further, the transcript of the same shall be uploaded on the website of the Company in due course. This for your information and records. Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper cuttings of the Public Notice intimating Shareholders to register/update their email address with the Company for receiving the Notice of the AGM, Annual Report and other documents/communication by an electronic mode published in Business Standard (All Editions) and Loksatta (Mumbai) on Monday, June 28, 2021. The said published Notice is available on the website of the Company at www.abbott.co.in. Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached Schedule of Meeting with the Institutional Shareholders/Analysts who have requested the Company for the same. Please note that no presentation will be made at the Meeting. Also, no Unpublished Price Sensitive Information pertaining to the Company will be shared at this Meeting. The said intimation is available on the website of the Company at www.abbott.co.in ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors approved the appointment of Ms Sabina Ewing (DIN: 09201770) as an Additional and Non-Executive Director on the Board of the Company effective June 15, 2021 to hold office upto the conclusion of the forthcoming Annual General Meeting of the Company. The additional details required under the Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed herewith as Annexure A. You are requested to take the same on record. Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors approved the appointment of Ms Sabina Ewing (DIN: 09201770) as an Additional and Non-Executive Director on the Board of the Company effective June 15, 2021 to hold office upto the conclusion of the forthcoming Annual General Meeting of the Company. The additional details required under the Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed herewith as Annexure A. You are requested to take the same on record.